Literature DB >> 16320246

Array CGH analysis of pediatric medulloblastomas.

Michael R Rossi1, Jeffrey Conroy, Devin McQuaid, Norma J Nowak, James T Rutka, John K Cowell.   

Abstract

Brain tumors are the second most common childhood cancer. We used high-resolution array comparative genomic hybridization (aCGH) to analyze losses and gains of genetic material from 24 medulloblastomas. The bacterial artificial chromosome clones were ordered on the array, allowing for an average resolution of approximately 420 kilobases. The advantage of this high resolution is that the breakpoints associated with subregional chromosome copy number aberrations can be accurately defined, which in turn allows candidate genes within these regions to be readily defined. In this analysis, we confirmed the frequent involvement of loss of 17p and gain of 17q, although we have now established the position of the breakpoint that consistently lies in the chr17:18318880-19046234 region of the chromosome. Other frequent losses were seen on 8p, 10q, 16q, and 20p, and frequent gains were seen on 2p, 4p, 7, and 19. In addition, the fine-resolution mapping provided by aCGH made it possible to define small chromosome deletions in 1q23.3-q24.2, 2q13.12-q13.2, 6q25-qter, 8p23.1, 10q25.1, and 12q13.12-q13.2. Overall, amplification events were rare, the most common involving MYC (16%), on 8q, although isolated events were seen in 10p11 and 3q.

Entities:  

Mesh:

Year:  2006        PMID: 16320246     DOI: 10.1002/gcc.20292

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  16 in total

Review 1.  Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.

Authors:  Mandeep S Tamber; Krishan Bansal; Muh-Lii Liang; Todd G Mainprize; Bodour Salhia; Paul Northcott; Michael Taylor; James T Rutka
Journal:  Childs Nerv Syst       Date:  2006-09-02       Impact factor: 1.475

Review 2.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

3.  High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromes.

Authors:  Christine L O'Keefe; Ramon Tiu; Lukasz P Gondek; Jennifer Powers; Karl S Theil; Matt Kalaycio; Alan Lichtin; Mikkael A Sekeres; Jaroslaw P Maciejewski
Journal:  Exp Hematol       Date:  2007-02       Impact factor: 3.084

4.  Genomic analysis of CD8+ NK/T cell line, 'SRIK-NKL', with array-based CGH (aCGH), SKY/FISH and molecular mapping.

Authors:  Michael R Rossi; Jeff Laduca; John K Cowell; Bejai I S Srivastava; Seiichi Matsui
Journal:  Leuk Res       Date:  2007-07-20       Impact factor: 3.156

5.  The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis.

Authors:  Kay Ka-Wai Li; Yan Qi; Tian Xia; Aden Ka-Yin Chan; Zhen-Yu Zhang; Abudumijiti Aibaidula; Rong Zhang; Liangfu Zhou; Yu Yao; Ho-Keung Ng
Journal:  Lab Invest       Date:  2017-05-15       Impact factor: 5.662

6.  HDM2 promotes WIP1-mediated medulloblastoma growth.

Authors:  Meghan C Buss; Tracy-Ann Read; Matthew J Schniederjan; Khanjan Gandhi; Robert C Castellino
Journal:  Neuro Oncol       Date:  2012-02-29       Impact factor: 12.300

7.  Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience.

Authors:  Dolly Aguilera; Claire Mazewski; Jason Fangusaro; Tobey J MacDonald; Rene Y McNall-Knapp; Laura L Hayes; Sungjin Kim; Robert C Castellino
Journal:  Childs Nerv Syst       Date:  2013-01-08       Impact factor: 1.475

8.  An interferon response gene expression signature is activated in a subset of medulloblastomas.

Authors:  Eike Staub
Journal:  Transl Oncol       Date:  2012-08-01       Impact factor: 4.243

Review 9.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

Review 10.  The evolution and application of techniques in molecular biology to human brain tumors: a 25 year perspective.

Authors:  James T Rutka; Paul Kongkham; Paul Northcott; Carlos Carlotti; Mustafa Guduk; Hirokatsu Osawa; Orlando Moreno; Ho Jun Seol; Andres Restrepo; Adrienne Weeks; Shoichi Nagai; Christian Smith
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.